Enfermedades emergentes y reemergentes en las Americas

Medicina

Volumn 58, Issue SUPPL. 1, 1998, Pages 2-13

  Schmuñis, Gabriel A ^a  

^a PAN AMERICAN HEALTH ORGANIZATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CHLORAMPHENICOL; COTRIMOXAZOLE; ERYTHROMYCIN; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; MEFLOQUINE; PENICILLIN G; QUININE; RIFAMPICIN; STREPTOMYCIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; CHOLERA; COMMUNICABLE DISEASE; CONFERENCE PAPER; DENGUE; EHRLICHIOSIS; HANTAVIRUS PULMONARY SYNDROME; HEMANGIOMATOSIS; HEMORRHAGIC FEVER; HEPATITIS C; HUMAN; LEGIONNAIRE DISEASE; LYME DISEASE; MALARIA; MICROSPORIDIOSIS; SUDDEN INFANT DEATH SYNDROME;

AMERICAS; ANIMALS; BACTERIAL INFECTIONS; COMMUNICABLE DISEASE CONTROL; DISEASE OUTBREAKS; DRUG RESISTANCE; HUMANS; PARASITIC DISEASES; RISK FACTORS; VIRUS DISEASES;

EID: 2542600840     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (93)

1. World Health Organization. The World Health Report. Bridging the gap. Executive summary. WHO 1995a; 1-5.
2. Pinner RW, Teutsch SM, Simonsen L, et al. Trends in infectious diseases mortality in the United States. JAMA 1996; 275: 189-93.
3. Garrett L. The return of infectious disease. Foreign Affairs 1996; 75: 665-79.
4. Wilson ME. Travel and the emergence of infectious diseases. Emerg Infect Dis 1995; 1: 39-46.
5. World Health Organization. Control of foodborne trematode infections. WHO 1995b; 849.
6. Epstein PR. Emerging diseases and ecosystem instability: New threats to public health. Am J Pub Hlth 1995, 85: 168-72.
7. Centers for Disease Control and Prevention. Addressing emerging infectious disease threats: a prevention strategy for the United States Atlanta, Ga: US Dep Hlth Human Services, Pub Hlth Serv, 1994.
8. Lederberg J, Shope RE, Oaks SC Jr. (eds). Emerging Infections: Microbial Threats to Health in the United States. Washington DC. Institute of Medicine, National Academy Press. 1992.
9. Satcher D. Emerging infections: getting ahead of the curve. Emerging Inf Dis 1995; 1: 1-6.
10. Morse SS. Factors in the emergence of infectious diseases. Emerging Inf Dis 1995; 1: 7-15.
11. Rodier G. WHO response to epidemics. Wld Hlth 1997; 50: 7-8.
12. Meslin FX, Stohr K, Formenty P. Emerging zoonoses. Wld Hlth 1997; 50: 18-9.
13. Thuriax M, Cherney S. AIDS affects us all. Wld Hlth 1997; 50: 20-1.
14. Heymann D. Emerging infectious diseases. Wld Hlth 1997; 50: 4-6.
15. Organización Panamericana de la Salud. Vigilancia de SIDA en las Américas. OPS/HCA/97. 006.
16. Oficina Sanitaria Panamericana. Situación del Cólera en las Américas. Inf No 17, 1997.
17. Organización Panamericana de la Salud. Dengue y fiebre hemorrágica del dengue, 1996. Boletín Epidemiol 1996; 17: 12-4
18. Organización Panamericana de la Salud. Plan continental de ampliación e intensificación del combate al Aedes aegypti. OPS/HCP/HCT/90/97.
19. Gubler DJ, Clark GG. Dengue/dengue hemorragic fever: the emergence of a global health problem. Emerging Inf Dis 1995; 1: 55-7.
20. McDade JE, Shepard CC, Fraser DW, Tsai TR, Redus MA, Dowdle WR, Laboratory Investigation Team. Legionnaires' disease. 2: Isolation of a bacterium and demonstration of its role in other respiratory disease. N Engl J Med 1977; 297: 1197-1203.
21. Skirrow MB, Campylobacter enteritis: a "new" disease. Br Med J 1977; 2: 9-11.
22. Nime FA, Burek JD, Page DL, et al. Acute enterocolitis in a human being infected with the protozoan Cryptosporidium. Gastroenterology 1976; 70: 592-8.
23. Riley LW, Remis RS, Helgerson SD, et al. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med 1983; 308: 681-5.
24. th Ed. New York: Churchill Livingstone, pp 2513-24, 1995.
25. Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davis JP. Lyme disease-a tick-borne spirochetosis? Science 1982; 216: 1317-9.
26. Dawson JE, Anderson BE, Fishbein DB, Sanchez JL, Goldsmith CS, Wilson KH, Duntley CW. Isolation and characterization of an Ehrlichia sp. from a patient diagnosed with human ehrlichiosis. J Clin Microbiol 1991; 29 2741-5.
27. Salas R, de Manzione N, Tesh RB, Rico-Hesse R, Shope RE, Betancourt A, et al. Venezuelan Hemorrhagic fever. Lancet 1991; 338: 1033-6.
28. Lopez Antunano FJ, Schmunis GA. Plasmodia of humans. In Parasitic protozoa. Kreir JP (ed). Amsterdam: Academic Press 1993; 5: 135-266.
29. American Society of Microbiology. Report of the ASM task force on antibiotic resistance. Washington DC: Am Soc Microbiol, 1995.
30. Tomasz A. Multiple antibiotic resistant pathogenic bacteria: a report on the Rockefeller University Workshop. N Eng J Med 1994; 330: 1247-51.
31. US Congress, Office of Technological Assessment. Impacts of antibiotic resistance bacteria. Washington DC. US Cong, OTA, Sept 1995.
32. Tenover FC, Hughes JM. The challenge of emerging infectious diseases. Development and spread of multiply-resistant bacterial pathogens JAMA 1996; 275: 300-4.
33. Shlossberg D, Morad Y, Krouse TB et al. Culture proved disseminated cat scratch disease in acquired immunodeficiency syndrome. Arch Intern Med 1989; 149: 1437-9.
34. Relman DA, Falkow S, Leboit PE, Perkocha LA, Min K-W, Welch DF, Slater LN. The organisms causing bacillary angiomatosis, peliosis hepatitis, and fever and bacteremia in immunocompromised patients. N Engl J Med 1991; 324: 1514.
35. Regnery RL, Anderson BE, Clarridge JE III, Rodriguez-Barradas MC, Jones DC, Carr JH. Characterization of a novel Rochalimaea species, R. Henselae sp. Nov., isolated from blood of a febrile, human immunodeficiency virus-positive patient. J Clin Microbiol 1992, 30: 265-74.
36. Welch DF, Picket DA, Slater LN, Steigerwalt Ag, Brenner DJ. Rochalimaea henselae sp. Nov., a cause of speticemia, bacillary angiomatosis, and parenchymal bacillary peliosis. J Clin Microbiol 1992; 30: 275-80
37. Adal KA, Cockerell CJ, Petne WA. Bacillary angiomatosis, cat scratch disease and other syndromes due to Rochalimaea. N Eng J Med 1993; 330: 1509-15.
38. Steere AC, Maliwista SE, Snydman DR et al. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum 1977; 20: 7-17.
39. Strikland GT, Trivedi L, Watkins BS, et al. Cluster of lyme disease cases at a summer camp in Kent county, Maryland. Emerg Inf Dis 1996; 2: 44-6.
40. CDC. Lyme disease-United States, 1996. MMWR 1996; 46: 531-5.
41. Mishu B, Ilyas AA, Koski CL, Vriesendorp F, Cook SD, Mithen Fa, et al. Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barré syndrome. Ann Intern Med, 1993; 118: 947-53.
42. Tauxe RV. Epidemiology of Campylobacter jejuni infections in the United States and other industrialized nations. In: Nachamkin I, Tompkins S, Blaser M, (eds). Campylobacter jejuni: Current Status and Future Trends. Washington DC: American Society for Microbiology, 1992.
43. MacDonald KL, O'Leary MJ, Cohen ML, et al. Escherichia coli 0157:H7, an emerging gastrointestinal pathogen. Results of a one-year prospective population-based study. JAMA 1988; 259: 3567-70.
44. Pai CH, Ahmed N, Lior H, et al. Epidemiology of sporadic diarrhea due to serocytotoxin-producing Escherichia coli: a two year prospective study. J Infect Dis 1988; 157: 1054-7.
45. Griffin PM, Tauxe RV. The epidemiology of infection caused by Esquerichia coli 0157:H7, other enterohemorragic E. coli and the associated hemolytic uremic syndrome Epidemiol Rev 1991; 13: 60-98.
46. Ortega YR, Sterling CR, Gilman RH, et al. Cyclospora species-a new protozoan pathogen of humans. N Engl J Med 1992; 328: 1308-12.
47. Soave R. Cyclospora: an overview. Clin Infect Dis 1996; 23: 429-37.
48. CDC. Update: outbreaks of Cyclospora cayetanensis infection. United States and Canada, 1996. MMWR 1996; 45: 611-2.
49. CDC. Outbreaks of Cyclosporiasis - United States, 1997. MMWR 1997; 48: 451-2.
50. Fraser D. Epidemiology of Giardia lamblia and cryptosporidium infections in childhood, Isr J Med Sci 1994; 30: 356-61.
51. Mac Kenzie WR, Hoxie NJ, Proctor ME, et al. A massive outbreak in Milwaukee of Ctyptosporidium infection transmitted through the public water supply. N Engl J Med 1994; 331: 161-7.
52. Wuhib T, Siva TMJ, Newman RD et al. Cryptosporidial and microsporidial infections in human immunodeficiency virus-infected patients in northeastem Brazil. J Inf Dis 1994, 170: 494-7.
53. Rey L. Parasitologia. 2da. Ed. Guanabara Koogan, Rio de Janeiro. 1991; p 268-9.
54. Anderson BE, Dawson JE, Jones DC, Wilson KH, Ehrlichia chaffeensis. A new species associated with human ehrlichiosis J. Clin Microbiol 199?, 29. 2838-42.
55. Walker DH, Dumler JS. Emergence of the Ehrlichioses as human health problems Emerg Inf Dis 1996; 2: 18-29.
56. PAHO. Regional plan of action for combating new, emerging, and re-emerging infectious diseases in the Americas. PAHO/HCP/HCT/ 95. 060.
57. Pan American Health Organization. Re-emergence of Bolivian hemorragic fever. Epidemiol Bull 1994; 15: 4-5.
58. PAHO. Fiebre hemorrágica Venezolana (FHV). Bol Epidemiol OPS 1995; 16: 9.
59. Peters CJ. Arenaviruses. In: Emerging viruses. Morse SS (ed), New York: Oxford University Press, 1993; 283-9.
60. th edition, 1995; 23-4.
61. Choo QL Kuo G, Weiner AJ, Overby LR, Bradley DW, Houthton M. Isolation of a cDNA derived from a blood-borne non-A, nonB viral hepatitis genome. Science 1989; 244: 359-61.
62. Schmunis GA, Zicker F, Pinheiro F, Brandling-Bennett D. Risk of transfusion-transmitted infectious diseases in Latin America. Emerging Inf Dis (in press).
63. Pinheiro FP, Travassos da Rosa APA, Vasconcellos PFC. Arboviral zoonosis of central and South America. Oroupuche fever: In: Beran (ed). Handbook of zoonoses, 2d edition, section B: Viral. Boca Raton Florida. CRC Press 1994; 214-7.
64. World Health Organization. Epidemiology, prevention and control of legionellosis: Memorandum from a WHO meeting. Bull WHO 1990; 68: 155-64.
65. Barré-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome. Science 1983; 220: 868-71.
66. Nichol ST, Spiropoulou CF, Morzunov S, Rollin PE, Ksiazek TG, Feldmann H, et al. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 1993; 262: 9147.
67. Zaki SR, Greer PW, Coffield LM, Goldsmith, C et al. Hanta-virus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am J Pathol 1995; 146: 552-79.
68. Meeting of the task force on surveillance for emerging and re-emerging infectious diseases. PAHO/HCP/HCT/97.001.
69. Wensel RP, Nettleman MD, Jones RN, Pfaller MA. Methicillin-resistant Staphylococcus aureus: implications for the 1990s and effective control measures. Am J Med 1991; 91: Suppl 3B, 3B-221S-3B-227S.
70. Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev, 1993; 6: 428-42.
71. Handwerger S, Raucher B, Altarac D, et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin Clin Infect Dis 1993; 16: 750-5.
72. Jacoby GA, Medeiros AA. More extended-spectrum betalactamases. Antimicrob Agents Chemother 1991; 35: 1697-704.
73. Kristinsson KG, Hjálmarsdóttir MA, Steingrímsson O. Increasing penicilin resistance in pneumococci in Iceland. Lancet 1992: 339: 1606-7.
74. Bradley JS, Connor JD. Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics. Pediatr Infect Dis J 1991; 10: 871-3.
75. Sloas MM, Barrett FF, Chesney PJ. et al. Cephalosporin treatment failure in penicillin -and cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediat Infec Dis J 1992; 11: 662-6.
76. Bloom BR, Murray CJL, Tuberculosis: commentary on a reemergent killer. Science 1992; 257: 1055-64.
77. Well D. Comunicación Personal.
78. Situación de los programas de malaria en las Américas. XLV informe. CD40/Inf/2.
79. Ruiz A, Navarro AM, Vargas E, Cobarrillas O, Sánchez J, Díaz M. Peste en Peru un enfoque multisectorial de control. Bol Ofic Sant Panam 1996; 121: 363-7.
80. Pan American Health Organization. The feasibility of erradicating Aedes aegypti in the Americas. Pan Am J Pub Hlth 1997; 1: 68-72.
81. Pan American Health Organization. Outbreak of Venezuelan equine encephalitis, 1995. PAHO Epidemiol Bull 1995; 16: 9-11.
82. Ruiz A. Brote de encefalitis equina venezolana. Pan Am J Pub Hlth 1997; 1: 78-83.
83. Alleyne GAO. What is the role of institutions in the developing world, New developments in tropical Medicine II. Ntl Council Int. Hlth Washington DC 9-14, 1982.
84. Patz JA, Epstein PR, Burke TA, Balbus JM. Global climate change and emerging infectious diseases. JAMA 1996, 275, 217-23.
85. Levy SB, Fitzgerald GB, Macone AB. Changes in intestinal flora of farm personnel after introduction of tetracycline-supplemented feed on a farm. N Eng J Med 1976; 295: 583-8.
86. Levy SB. Emergence of antibiotic-resistance bacteria in the intestinal flora of farm inhabitants. J Infect Dis 1995; 137: 689-90
87. Berkelman RL, Bryan RT, Osterholm MT, LeDuc JW, Hughes JM. Infectious disease surveillance: a crumbling foundation. Science 1994; 264: 368-70.
88. NIAID. Report of the Task Force on Microbiology and Infectious Disease. US Department of Health and Human Services, Public Health Service, National Institutes of Health. NIH Publication 92-3320, 1992.
89. CDC. The Center for Infectious Diseases: Toward the Year 2000. CDC, Public Health Service, Department of Health and Human Services, 1990.
90. CDC. Public health focus: surveillance, prevention, and control of nosocomial infections. MMWR; 1992; 41: 783-7.
91. Espinosa Ferrando J. Estimate of the costs of the dengue epidemic in 1994; in Nicaragua. OPS/HCP/HCT/95.64.
92. Glanz K, Yang H. Communicating about risk of infectious diseases. JAMA 1996; 275: 253-6.
93. Plotkin BJ, Kimball AM. Designing an international policy and legal framework for the control of emerging infectious diseases: first steps. Emerg Inf Dis 1997; 3: 1-9.